Regulatory approval of a new Johnson & Johnson tool opens a new category in surgical robotics, the MedTech company said in a presentation released Tuesday (Oct. 13) in conjunction with its third-quarter earnings call. Johnson & Johnson’s new OTTAVA table-integrated soft tissue robotic system achieved U.S. Food and Drug Administration market authorization during the quarter. […]
The post J&J Spotlights FDA-Approved Surgical Robot Amid $100 Billion Revenue Push appeared first on PYMNTS.com .
